Dupilumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dupilumab and local guidelines before prescribing.

Biologic (IL-4/IL-13)

Mechanism

IL-4 and IL-13 receptor monoclonal antibody.

Uses

Atopic dermatitis, asthma, chronic rhinosinusitis with polyps, eosinophilic oesophagitis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reactions, conjunctivitis, eosinophilia, herpes infections.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active parasitic infection

Monitoring

Eosinophils, eye symptoms

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Treat helminth infection before starting; conjunctivitis common in eczema patients.

More from the textbook: uses, cautions and other points
Where it is discussed in the book